Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 248-469-2 | CAS number: 27458-92-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
90 -day, rat: NOAEL = 150mg/kg, based on effects on body weight, clinical chemistry and urinanalysis, excluding peroxisome proliferation (BASF 1996, OECD 408, GLP) - data generated for CAS 10042 -59 -8
14 -day screening, male rats (Rhodes et al., 1983)
no effects on testes, liver, and body weight at 1mM/kg b.w.
NOAEL = 184 mg/kg bw (Isotridecanol, CAS 27458 -92 -0)
NOAEL = 168 mg/kg bw (Isodecanol, CAS 25339 -17 -7)
NOAEL = 144 mg/kg bw (Isononanol, CAS 27458 -94 -2)
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Link to relevant study records
- Endpoint:
- sub-chronic toxicity: oral
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- see justification attached to chapter 13
- Reason / purpose for cross-reference:
- read-across source
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- 150 mg/kg bw/day (actual dose received)
- Sex:
- male/female
- Basis for effect level:
- body weight and weight gain
- clinical biochemistry
- urinalysis
- Critical effects observed:
- yes
- Lowest effective dose / conc.:
- 600 mg/kg bw/day (actual dose received)
- System:
- hepatobiliary
- Organ:
- kidney
- liver
- Treatment related:
- yes
- Dose response relationship:
- yes
- Relevant for humans:
- yes
- Endpoint:
- short-term repeated dose toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Principles of method if other than guideline:
- Comparative screening study to investigate selectively the effect on testis and liver morphology and function.
- GLP compliance:
- not specified
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: ICI Alderley Park, UK
- Housing: single
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 1 week - Route of administration:
- oral: gavage
- Vehicle:
- polyethylene glycol
- Details on oral exposure:
- Application volume: 10 ml/kg bw
- Analytical verification of doses or concentrations:
- not specified
- Duration of treatment / exposure:
- 14 d
- Frequency of treatment:
- daily
- Dose / conc.:
- 184 mg/kg bw/day (actual dose received)
- Remarks:
- 1 mM/kg bw
- No. of animals per sex per dose:
- 10 per control group, 5 per dose group
- Control animals:
- yes, concurrent vehicle
- Observations and examinations performed and frequency:
- Body weights were determined. The animals were killed by halothane overdose and blood samples for clinical pathology (plasma cholesterol and plasma triglyceride) were taken. The liver was weighed and samples for light and electron microscopy, morphometric analysis were investigated. Remaining liver was processed for investigation of catalase and CN-insensitive palmitoyl CoA oxidation.
- Dose descriptor:
- NOEL
- Effect level:
- 184 mg/kg diet
- Based on:
- test mat.
- Sex:
- male
- Basis for effect level:
- other: No effects observed
- Critical effects observed:
- no
- Endpoint:
- short-term repeated dose toxicity: oral
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Principles of method if other than guideline:
- Comparative screening study to investigate selectively the effect on testis and liver morphology and function.
- GLP compliance:
- not specified
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: ICI Alderley Park, UK
- Housing: single
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 1 week - Route of administration:
- oral: gavage
- Vehicle:
- polyethylene glycol
- Details on oral exposure:
- Application volume: 10 ml/kg bw
- Analytical verification of doses or concentrations:
- not specified
- Duration of treatment / exposure:
- 14 d
- Frequency of treatment:
- daily
- Dose / conc.:
- 168 mg/kg bw/day (actual dose received)
- Remarks:
- 1 mM/kg bw
- No. of animals per sex per dose:
- 10 per control group, 5 per dose group
- Control animals:
- yes, concurrent vehicle
- Observations and examinations performed and frequency:
- Body weights were determined. The animals were killed by halothane overdose and blood samples for clinical pathology (plasma cholesterol and plasma triglyceride) were taken. The liver was weighed and samples for light and electron microscopy, morphometric analysis were investigated. Remaining liver was processed for investigation of catalase and CN-insensitive palmitoyl CoA oxidation.
- Dose descriptor:
- NOAEL
- Effect level:
- 168 mg/kg bw/day (actual dose received)
- Sex:
- male
- Basis for effect level:
- other: no effects observed
- Critical effects observed:
- no
- Endpoint:
- short-term repeated dose toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Principles of method if other than guideline:
- Comparative screening study to investigate selectively the effect on testis and liver morphology and function.
- GLP compliance:
- not specified
- Limit test:
- no
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: ICI Alderley Park, UK
- Housing: single
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 1 week - Route of administration:
- oral: gavage
- Vehicle:
- polyethylene glycol
- Details on oral exposure:
- Animals received a dose level equivalent of 1 mmol/kg/day dissolved in polyethylene glycol 300 (10 ml/kg/day)
- Analytical verification of doses or concentrations:
- not specified
- Duration of treatment / exposure:
- 14 days
- Frequency of treatment:
- Once daily
- Dose / conc.:
- 144 mg/kg bw/day (actual dose received)
- Remarks:
- 1mM /kg b.w.
- No. of animals per sex per dose:
- 10 per control group, 5 per dose group
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- No data provided.
- Positive control:
- No data provided.
- Observations and examinations performed and frequency:
- Body weights were determined. The animals were killed by halothane overdose and blood samples for clinical pathology (plasma cholesterol and plasma triglyceride) were taken. The liver was weighed and samples for light and electron microscopy, morphometric analysis were investigated. Remaining liver was processed for investigation of catalase and CN-insensitive palmitoyl CoA oxidation.
- Sacrifice and pathology:
- Morphology of the liver.
- Dose descriptor:
- NOAEL
- Effect level:
- 144 mg/kg bw/day (actual dose received)
- Sex:
- male
- Basis for effect level:
- other: no effects observed
- Critical effects observed:
- no
- Executive summary:
In a two-week oral study, five male rats were dosed by oral gavage with 144 mg/kg bw/day of isononanol. In the control group, ten animals received the vehicle, PEG (polyethylene glycol) 300, daily for 14 days. Animals were sacrificed after 14 days and blood was analyzed for plasma cholesterol and triglycerides. The liver was removed for histopathological analysis, analysis of catalase, and CN-insensitive palmitoyl CoA oxidation. Testicular weight was also determined. Isononanol did not significantly influence bodyweight gain, liver to bodyweight ratio, testis to bodyweight ratio, or palmitoyl CoA oxidase activity. It is concluded that the NOAEL is 144 mg/kg/day.
Referenceopen allclose all
Tridecanol did not impair body weight and had no effect on relative liver and testis weight. Neither clinical pathology parameter nor peroxisome associated enzymes were affected. Liver histology differed not from the concurrent control group.
Isodecanol did not impair body weight and had no effect on relative liver and testis weight. Neither clinical pathology parameter nor peroxisome associated enzymes were affected. Liver histology differed not from the concurrent control group.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- NOAEL
- 150 mg/kg bw/day
- Study duration:
- subchronic
- Species:
- rat
Additional information
No subchronic study for the registered substance is available. Instead, data from the structurally related branched alcohol propylheptanol (CAS 10042-59-8) were adopted. For a detailed justification of this approach, please see the attached document to IUCLID chapter 13.
Animals were observed for clinical signs at least daily. Gross and microscopic examinations were performed on all animals from all dosage groups. Also, clinical chemistry, haematology, urinalysis or ophthalmoscopic examinations were conducted and organ weights were taken. Substance-related effects were seen at 600 mg/kg in both sexes and at 150 mg/kg in one female, only.
No substance-related deaths occurred. All high dose males and females showed salivation one hour after administration and urine-smeared fur in the anogenital region was recorded for males and females for 3 to 4 hours after administration. Reduced food consumption was recorded in animals of both sexes as well as impaired body weight gain including reduced body weights at the end of administration in males. Ophthalmoscopy revealed no treatment-related changes. Haematology showed a decrease in platelets. The toxicological relevance of this singular finding is unclear. Globulins and cholesterol were decreased in both sexes and triglycerides only in males, while albumin was increased. These changes might be indicative of increased liver metabolism. There was also an increase in cyanide- insensitive palmitoyl-CoA-oxidation in both sexes, which is typical for peroxisome proliferation. Correspondingly, pathology showed an increased absolute and relative liver weight in both sexes, which was associated with diffuse hepatic hypertrophy. There was also a loss of fatty infiltration of liver cells in males only. Diffuse follicular hypertrophy in the thyroid gland in males and vacuolation of basophilic (thyrotrophic) cells in the glandular part of the pituitary gland in males are also secondary to peroxisome proliferation and parallel induced xenobiotic metabolism, which results in an increased elimination of T3/T4 from rat serum by increased glucuronidation. In females, the urinary volume was increased, leading to a reduced specific gravity. The number of squamous epithelial cells in urine were increased in both sexes. Females additionally had more transitional epithelial cells in the urine.
At 150 mg/kg bw/day, one female showed diffuse hepatic hypertrophy, resulting in an increase in relative liver weight in one female only.
Thus, the NOAEL was 150 mg/kg bw/day in males and 30 mg/kg bw/day in females mainly based on liver effects indicative for peroxisomal proliferation. Peroxisomal proliferation is a rodent-specific effect and not relevant for human hazard. Therefore the NOAEL relevant for human hazard is 150 mg/kg bw based on body weight effects and urinalysis.
A comparative screening study was conducted to investigate selectively the effect on testis and liver morphology and function for several branched long chain primary alcohols used as read across substances (isodecyl alcohol and Isononyl alcohol) and the registered substance itself (Rhodes, C. et al., 1983). The test substance (1mM/kg bw in polyethylene glycol 300) was administered orally via gavage to 5 male Wistar rats on 14 consecutive days. Body weights were determined. The animals were killed by halothane overdose and blood samples for clinical pathology (plasma cholesterol and plasma triglyceride) were taken. The liver was weighed and samples for light and electron microscopy, morphometric analysis were investigated. The remaining liver was processed for investigation of catalase and CN-insensitive palmitoyl CoA oxidation. None of the three tested alcohols impaired body weight or had any effect on relative liver and testis weight. Neither clinical pathology parameter nor peroxisome associated enzymes were affected. Liver histology did not differ from the concurrent control group. Dose levels were 144 mg/kg for isononanol, 168 mg/kg for isodecanol, and 184 mg/kg for isotridecanol.
Justification for classification or non-classification
In a subchronic study, effects on liver and kidney were observed at 600mg/kg. This is above the threshold for classification according to 1272/2008/EC (CLP).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.